Thompson Street Capital Partners Portfolio Company OpenClinica Acquires BuildClinical

Deal News | Dec 10, 2024 | Thompson Street Capital Partne

Thompson Street Capital Partners Portfolio Company OpenClinica Acquires BuildClinical

Thompson Street Capital Partners (TSCP), a private equity firm, has announced the acquisition of BuildClinical by its portfolio company OpenClinica. BuildClinical is renowned for its patient recruitment solutions for academic researchers, while OpenClinica provides eClinical software solutions. This merger is set to create a comprehensive suite of solutions for patient recruitment, consent, enrollment, and data capture in clinical trials. BuildClinical's expertise in academic research recruitment will complement OpenClinica's expansive network within the clinical trial ecosystem, comprising relationships with CROs, pharma sponsors, biotechs, and medical device companies. Leaders from both companies have expressed optimism about the synergies expected from this alliance. TSCP, which orchestrated the acquisition, is enthusiastic about the potential benefits for advancing clinical research. Transaction terms remain undisclosed. BuildClinical received advisory support from Edgemont Partners and Ice Miller, while OpenClinica was advised by Stout Capital and Bryan Cave Leighton Paisner.

Sectors

  • Healthcare Technology
  • Private Equity
  • Pharmaceuticals & Biotechnology

Geography

  • United States – The article's context involves TSCP, OpenClinica, and BuildClinical, all operating in the U.S. market.

Industry

  • Healthcare Technology – Involves technology solutions within the healthcare sector, such as eClinical software and digital recruitment solutions for clinical trials.
  • Private Equity – Engages in investment and acquisition activities, exemplified by TSCP's investment in OpenClinica and subsequent acquisition of BuildClinical.
  • Pharmaceuticals & Biotechnology – Relates to the clinical trials sector, which is a key area for both OpenClinica's and BuildClinical's operations with pharma sponsors and biotechs.

Financials

  • Not disclosed – The financial terms of the transaction between OpenClinica and BuildClinical.

Participants

NameRoleTypeDescription
Thompson Street Capital Partners (TSCP)Private Equity FirmCompanyA private equity firm based in St. Louis that owns portfolio company OpenClinica.
OpenClinicaAcquirer/Portfolio CompanyCompanyA provider of eClinical software solutions and a portfolio company of TSCP.
BuildClinicalTarget CompanyCompanyA health technology company focused on patient recruitment solutions for academic researchers.
Edgemont PartnersFinancial Advisor to BuildClinicalCompanyProvided financial advisory services to BuildClinical in the acquisition process.
Ice MillerLegal Advisor to BuildClinicalCompanyProvided legal advisory services to BuildClinical.
Stout CapitalFinancial Advisor to OpenClinicaCompanyProvided financial advisory services to OpenClinica in the acquisition process.
Bryan Cave Leighton PaisnerLegal Advisor to OpenClinicaCompanyProvided legal advisory services to OpenClinica.